Sacituzumab govitecan

Synonyms: IMMU-132

For research use only. Not for use in humans.

Home Biosimilar Antibodies Others ADC inhibitor Sacituzumab govitecan

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38, showing anticancer activity. Sacituzumab govitecan has a molecular weight of 160KDa. This product is supplied as 10mg/ml PBS solution.

Sacituzumab govitecan

CAS No. 1491917-83-9 (Sacituzumab govitecan)

Selleck's Sacituzumab govitecan Has Been Cited by 2 Publications

Purity & Quality Control

Batch: Purity: 98.93% Protein concentration: 10mg/ml Endotoxin Level: ＜1EU/mg
98.93

Sacituzumab govitecan Specificity

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38, showing anticancer activity. Sacituzumab govitecan has a molecular weight of 160KDa. This product is supplied as 10mg/ml PBS solution.

Product Details

CAS No. 1491917-83-9 (Sacituzumab govitecan)
Molecular Weight 160000
DAR 7.6
ADC antiody Sacituzumab
ADC cytotoxin SN-38
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.